Hopstem
Dr. Fan has been elected as one of the' 30 Global Innovative talents of Chinese entrepreneurs' in 2018. 17 years of research experience in stroke and neurodegenerative disease models and mechanisms. 10 years of experience in pluripotent stem cell culture, iPSC reprogramming and neural differentiation. Since 2017, Dr. Fan has led the Hopstem team and together established the company's IPs and iPSC cell product R&D platform. Previous Postdoctoral fellow of Neurology and ICE, Johns Hopkins University. Dr. Fan holds a B.S. in Life Science, Peking University and Ph.D. in Neuroscience, University of British Columbia.
This person is not in any offices
Hopstem
Hopstem is a pharmaceutical company engaged in human iPSCs/ESCs neural differentiation, cell banking, and cell engineering.